Climbing RAS, the everest of oncogenes

Research output: Contribution to journalArticlepeer-review


Mutations that activate the small GTP-binding protein KRAS are the most common oncogenic event in human tumors. Thirty years after its discovery, mutant KRAS has yet to be therapeutically conquered.

Original languageEnglish
Pages (from-to)19-21
Number of pages3
JournalCancer Discovery
Issue number1
Publication statusPublished - Jan 2014

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Climbing RAS, the everest of oncogenes'. Together they form a unique fingerprint.

Cite this